ArticleBioData mining2025
Feature graphs for interpretable unsupervised tree ensembles: centrality, interaction, and application in disease subtyping.
Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Counterfactual explanations of tree based ensemble models for brain disease analysis with structure function coupling.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Explainable and interpretable machine learning has emerged as essential in leveraging artificial intelligence within high-stakes domains such as healthcare to ensure transparency and trustworthiness. Feature importance analysis plays a crucial role in improving model interpretability by pinpointing the most relevant input features, particularly in disease subtyping applications, aimed at stratifying patients based on a small set of signature genes and biomarkers. While clustering methods, including unsupervised random forests, have demonstrated good performance, approaches for evaluating feature contributions in an unsupervised regime are notably scarce. To address this gap, we introduce a novel methodology to enhance the interpretability of unsupervised random forests by elucidating feature contributions through the construction of feature graphs, both over the entire dataset and individual clusters, that leverage parent-child node splits within the trees. Feature selection strategies to derive effective feature combinations from these graphs are presented and extensively evaluated on synthetic and benchmark datasets against state-of-the-art methods, standing out for performance, computational efficiency, reliability, versatility and ability to provide cluster-specific insights. In a disease subtyping application, clustering kidney cancer gene expression data over a feature subset selected with our approach reveals three patient groups with different survival outcomes. Cluster-specific analysis identifies distinctive feature contributions and interactions, essential for devising targeted interventions, conducting personalised risk assessments, and enhancing our understanding of the underlying molecular complexities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.